S&P 500
7,588.60
+0.51%
Dow Jones
52,758.90
+0.47%
Nasdaq 100
29,885.70
+0.46%
Russell 2000
2,982.51
-0.27%
FTSE 100
10,543.60
+0.61%
Nikkei 225
69,317.20
+0.42%

Investing

Morning Analyst Calls Briefing for Monday, November 21, 2022 

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Morning Analyst Calls Briefing for Monday, November 21, 2022 

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Canadian Natrl Res (CNQ) upgraded to Buy from Neutral at Goldman; tgt raised to $69

> Mueller Water (MWA) upgraded to Buy from Neutral at Northcoast

> On (ONON) upgraded to Buy from Neutral at Goldman; tgt lowered to $28

> Walt Disney (DIS) upgraded to Outperform from Market Perform at MoffettNathanson; tgt $120

Downgrades:

> American Homes 4 Rent (AMH) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $33

> Aveanna (AVAH) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3

> Cenovus Energy (CVE) downgraded to Neutral from Buy at Goldman; tgt $23

> Cigna (CI) downgraded to Outperform from Strong Buy at Raymond James; tgt $370

> ConocoPhillips (COP) downgraded to Sell from Hold at Societe Generale; tgt $114

> EverCommerce (EVCM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $9

> Extra Space Storage (EXR) downgraded to Underperform from In-line at Evercore ISI; tgt lowered to $150

> Federal Signal (FSS) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets

> Four Corners Property Trust (FCPT) downgraded to In-line from Outperform at Evercore ISI; tgt $28

> Kimco Realty (KIM) downgraded to In-line from Outperform at Evercore ISI; tgt $22

> MongoDB (MDB) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $215

Others:

> Affiliated Managers (AMG) resumed with a Buy at Goldman; tgt $182

> Apollo Commercial Real Estate (ARI) resumed with a Neutral at BofA Securities; tgt $12

> Cue Biopharma (CUE) initiated with an Overweight at Piper Sandler; tgt $7

> ImmunoGen (IMGN) initiated with a Buy at Truist; tgt $10

> Mersana Therapeutics (MRSN) initiated with a Buy at Truist; tgt $12

> Mobileye Global (MBLY) initiated with a Buy at Citigroup; tgt $77

> Mobileye Global (MBLY) initiated with a Buy at Goldman; tgt $36

> Mobileye Global (MBLY) initiated with a Buy at Mizuho; tgt $35

> Mobileye Global (MBLY) initiated with a Buy at Needham; tgt $40

> Mobileye Global (MBLY) initiated with a Neutral at BofA Securities; tgt $34

> Mobileye Global (MBLY) initiated with a Peer Perform at Wolfe Research

> Mobileye Global (MBLY) initiated with a Strong Buy at Raymond James; tgt $50

> Mobileye Global (MBLY) initiated with an Outperform at Cowen; tgt $35

> Mobileye Global (MBLY) initiated with an Outperform at RBC Capital Mkts; tgt $41

> MongoDB (MDB) initiated with an Overweight at KeyBanc Capital Markets; tgt $215

Research calls posted earlier this morning are available here.  

Contact [email protected] for any questions or corrections.

Disclaimer: Energy Exploration Technologies, Inc. ("EnergyX") has engaged 24/7 Wall St to publish this communication in connection with EnergyX's ongoing Regulation A offering. 24/7 Wall St has been paid in cash and may receive additional compensation. 24/7 Wall St and/or its affiliates do not currently hold securities of EnergyX.

This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX's offering materials. EnergyX's Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/.

Comparisons to other companies are for informational purposes only and should not imply similar results. Past performance is not indicative of future results. Market shortfall are forward‑looking estimates and are subject to substantial uncertainty. Investments in private placements, and start-up investments in particular, are long-term, illiquid, speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups

Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year
Drew Wood |

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year
Five HYSA Mistakes That Quietly Cost You Money
Austin Smith |

Five HYSA Mistakes That Quietly Cost You Money

Continue Reading

Late Morning Analyst Calls Briefing for Monday, November 21, 2022 
Paul Ausick |

Late Morning Analyst Calls Briefing for Monday, November 21, 2022 

Here are Monday's latest reported analyst calls.

Morning Analyst Calls Briefing for Thursday, November 17, 2022 
Paul Ausick |

Morning Analyst Calls Briefing for Thursday, November 17, 2022 

More analyst calls released Thursday morning.

First Look Analysts Research Calls for Tuesday, December 13
Paul Ausick |

First Look Analysts Research Calls for Tuesday, December 13

Here are early analyst calls published Tuesday morning.

Opening Bell Analysts Research Calls for Friday, January 13
Paul Ausick |

Opening Bell Analysts Research Calls for Friday, January 13

This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here.   Upgrades:…

Opening Bell Analysts Research Calls for Monday, February 27
Paul Ausick |

Opening Bell Analysts Research Calls for Monday, February 27

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here. Upgrades: >…

Opening Bell Analysts Research Calls for Tuesday, March 7
Paul Ausick |

Opening Bell Analysts Research Calls for Tuesday, March 7

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.  Upgrades: >…

Opening Bell Analysts Research Calls for Monday, January 9
Paul Ausick |

Opening Bell Analysts Research Calls for Monday, January 9

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.   Upgrades:…

Opening Bell Analysts Research Calls for Tuesday, February 7
Paul Ausick |

Opening Bell Analysts Research Calls for Tuesday, February 7

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.   Upgrades: >…

Morning Analyst Calls Briefing for Friday, November 4, 2022 
Paul Ausick |

Morning Analyst Calls Briefing for Friday, November 4, 2022 

More analyst research calls for Friday, November 4.

Top Gaining Stocks

Meta
META • Vol: 40,760,422
CarMax
KMX • Vol: 2,288,021
Weyerhaeuser
WY • Vol: 6,523,553
SBA Communications
SBAC • Vol: 1,443,801
NVIDIA
NVDA • Vol: 148,249,982

Top Losing Stocks

Moderna
MRNA • Vol: 9,176,778
Coterra Energy
CTRA • Vol: 73,319,495
CrowdStrike
CRWD • Vol: 9,269,567
Datadog
DDOG • Vol: 5,135,556
EPAM Systems
EPAM • Vol: 1,164,561